2016
DOI: 10.1111/tmi.12817
|View full text |Cite
|
Sign up to set email alerts
|

Impact of the zero‐markup drug policy on hospitalisation expenditure in western rural China: an interrupted time series analysis

Abstract: A statistically significant absolute decrease in the level or trend of monthly average hospitalisation expenditure and monthly average hospitalisation expenditure after reimbursement was detected after the introduction of the zero-markup drug policy in western China. However, hospitalisation expenditure and hospitalisation expenditure after reimbursement were still increasing. More effective policies are needed to prevent these costs from continuing to rise.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
27
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 33 publications
(29 citation statements)
references
References 11 publications
1
27
1
Order By: Relevance
“…There are two typical mark-up drug policies, one is Fixed Percent Mark-up Drug (FPM) policy, which allows drugs to be sold on fixed mark-up percent based on the purchase price; the other is Zero Mark-up Drug (ZMD) policy, which requires all public hospitals to prescribe drugs at purchase price without including a mark-up (23). Previous studies mostly presented positive effects on healthcare expenditures shortly after implementing ZMD policy, but showed mixed results regarding long-term effects (11,14,24). Regarding FPM policy, hospitals were found to show more preference for expensive drugs, which led to increasing healthcare expenditures and high drug revenue proportion in both outpatient and inpatient healthcare revenue (9,25).…”
Section: Original Articlementioning
confidence: 99%
“…There are two typical mark-up drug policies, one is Fixed Percent Mark-up Drug (FPM) policy, which allows drugs to be sold on fixed mark-up percent based on the purchase price; the other is Zero Mark-up Drug (ZMD) policy, which requires all public hospitals to prescribe drugs at purchase price without including a mark-up (23). Previous studies mostly presented positive effects on healthcare expenditures shortly after implementing ZMD policy, but showed mixed results regarding long-term effects (11,14,24). Regarding FPM policy, hospitals were found to show more preference for expensive drugs, which led to increasing healthcare expenditures and high drug revenue proportion in both outpatient and inpatient healthcare revenue (9,25).…”
Section: Original Articlementioning
confidence: 99%
“…We excluded 25 records that did not meet our inclusion criteria. Nine studies (included time series study, retrospective cohort study, and quasi-experimental study) were included in this systematic review [1][2][3][4][6][7][8][9][10]. The characteristics of the included studies are summarized in Table 3.…”
Section: Characteristics Of the Included Trialsmentioning
confidence: 99%
“…A retrospective longitudinal study indicated that in absolute terms, there were increased annual patient-visits [6]. Yang et al (2017) indicated the statistically significant decreasing of monthly hospitalization expenditure [2]. Fu et al (2018) showed that a rise in expenditures for medical services and no changes in total health expenditures [8].…”
Section: Total Expensesmentioning
confidence: 99%
See 2 more Smart Citations